NCT06326632

Brief Summary

This study aimed to compare the effect of constant-load aerobic exercise (CL-AE) and graded aerobic exercise (G-AE) on cardiopulmonary fitness, and functional capacity in a cohort of obese children with bronchial asthma (BA). A total of 78 children with BA were randomly assigned to the CL-AE group (n = 26, who underwent moderate-intensity aerobic training with the training load maintained at the same level throughout the entire program, besides the respiratory re-training program), the G-AE group (n = 26, received an intensity- and duration-graded aerobic training in addition to the respiratory re-training program), or the control group (n = 29, who only engaged in a respiratory re-training program). Interventions were administered three times/week for 12 successive weeks. The cardiopulmonary fitness and functional capacity were evaluated in the three groups before and after the completion of the assigned interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 30, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 7, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 7, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 17, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 22, 2024

Completed
Last Updated

March 22, 2024

Status Verified

March 1, 2024

Enrollment Period

1.1 years

First QC Date

March 17, 2024

Last Update Submit

March 17, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Peak oxygen uptake

    The peak oxygen uptake (mL/kg/min) was assessed through a symptom-free exercise tolerance test (i.e., the McMaster cycling protocol).

    3 months

Secondary Outcomes (3)

  • Six-minute walk test

    3 months

  • Dyspnea

    3 months

  • Fatigue

    3 months

Study Arms (3)

CL-AE group

EXPERIMENTAL

The CL-AE group received a 12-week constant-load aerobic training besides the respiratory retraining program.

Other: Constant-load Aerobic Exercise

G-AE group

EXPERIMENTAL

The G-AE group received a 12-week intensity- and duration-graded aerobic training in addition to the respiratory re-training.

Other: Graded Aerobic exercise

Control group

ACTIVE COMPARATOR

The control group received the respiratory re-training only for 12 consecutive weeks.

Other: Respiratory Re-training

Interventions

The CL-AE group received a 12-week aerobic training, three times in addition to the respiratory re-training. the program included a moderate-intensity aerobic training program, with an intensity set at 65% of the maximum age-predicted heart rate for 45 minutes. The training intensity and duration were maintained at the same level throughout the program. The CL-AE program included a warm-up for 5 minutes and a cool-down for 5 minutes

CL-AE group

The G-AE group received a 12-week intensity- and duration-graded aerobic training, three times in addition to the respiratory re-training. The G-AE program commenced with a training intensity corresponding to 50% of the maximum age-predicted heart rate for 25 minutes in the first two weeks, which progressed on a two-week basis, and ended up with a training intensity corresponding to 75% of the maximum age-predicted heart rate for 50 minutes in the last two weeks. The G-AE program also included a warm-up for 5 minutes and a cool-down for 5 minutes.

G-AE group

The respiratory re-training lasted for 30 minutes per session and was repeated three times a week for 12 consecutive weeks. The program consisted of diaphragmatic breathing exercises, breath-hold, and breathing control exercises, pursed lip breathing, respiratory muscle strengthening, postural correction exercises, and relaxation techniques.

Control group

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age of 8-18 years
  • Body mass index ranging from 30 to 35 kg/m2
  • Verified asthma diagnosis per the Global Initiative for Asthma (GINA) criteria
  • Moderate Onset
  • Clinically Stable
  • Maintained medication dosages in the past three months
  • Free of lower limb or spinal deformities
  • Not engaging in regular exercise regimens in the past six months.

You may not qualify if:

  • Exacerbated asthma symptoms
  • Chronic lung comorbidities
  • Cardiovascular or musculoskeletal conditions expected to hinder the training.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ragab K. Elnaggar

Al Kharj, Riyadh Region, Saudi Arabia

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Ragab K. Elnaggar, PhD

    Prince Sattam Bin Abdulaziz University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
A single-blind protocol was adopted. The researcher who collected the data was blind to the allocation of treatment
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A prospective, three-arm, randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 17, 2024

First Posted

March 22, 2024

Study Start

October 30, 2022

Primary Completion

December 7, 2023

Study Completion

December 7, 2023

Last Updated

March 22, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations